CPRX logo

CPRX

Catalyst Pharmaceuticals Inc.

$20.59
+$0.21(+1.03%)
49
Overall
80
Value
18
Tech
--
Quality
Market Cap
$2.44B
Volume
814.40K
52W Range
$19.00 - $26.58
Target Price
$34.00
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
------$500.0K$102.3M$119.1M$140.8M$214.2M$398.2M$491.7M
Total Revenue
------$500.0K$102.3M$119.1M$140.8M$214.2M$398.2M$491.7M
COST OF GOODS SOLD
Cost of Revenue
--------$14.8M$17.0M$21.9M$34.4M$52.0M$68.8M
GROSS PROFIT
Gross Profit
------$500.0K$87.5M$102.0M$118.9M$179.8M$346.2M$422.9M
OPERATING EXPENSES
Operating Expenses
$-20.4M$-19.3M$-18.7M$35.8M$55.7M$60.7M$66.6M$78.0M$226.9M$190.4M
Research & Development
$11.8M$11.4M$11.4M$19.9M$18.8M$16.5M$16.9M$19.8M$93.2M$12.6M
Research Expense
$11.8M$11.4M$11.4M$19.9M$18.8M$16.5M$16.9M$19.8M$93.2M$12.6M
Selling, General & Administrative
$8.6M$7.9M$7.3M$15.9M$36.9M$44.2M$49.6M$57.1M$133.7M$177.7M
Selling & Marketing Expenses
------$15.9M--------$91.5M$118.7M
General & Administrative Expenses
$8.6M$7.9M$7.3M$-242.2K$36.9M$44.2M$49.6M$57.1M$133.7M$177.7M
Salaries & Wages
$-1.6M$-1.8M$-2.4M$-3.6M$3.8M$6.3M$6.1M$7.9M$14.3M$22.3M
Depreciation & Amortization
$-34.5K$-43.4K$-45.7K$-38.0K------------
Depreciation & Amortization
$-34.5K$-43.4K$-45.7K$-38.0K------------
Amortization
--------------$1.1M$32.6M$37.4M
Other Operating Expenses
--$-10.0K$-10.0K--$296.3K$300.0K$400.0K$431.0K$226.9M$190.4M
OPERATING INCOME
Operating income
$-20.4M$-19.3M$-18.7M$-35.3M$31.8M$41.3M$52.4M$101.8M$86.8M$195.1M
EBITDA
$-20.2M$-18.0M$-18.4M$-34.0M$33.5M$41.4M$52.6M$106.0M$127.4M$254.0M
NON-OPERATING ITEMS
Gain on Sale of Securities
------$20.2K$80.0K------$3.0M$5.1M
Other Income/Expense
$-165.4K$-1.2M$-267.3K$-1.3M$-1.6M$-587.0K$-282.0K$2.9M$-7.7M$-21.1M
Other Special Charges
$165.4K$1.2M$267.3K$1.3M$1.6M$587.0K$282.0K$2.9M$7.7M$21.1M
SPECIAL ITEMS
Special Income Charges
$-3.5M------------------
PRE-TAX INCOME
EBIT
$-20.2M$-18.1M$-18.4M$-34.0M$33.4M$41.3M$52.4M$104.7M$94.5M$216.3M
Pre-Tax Income
$-20.2M$-18.1M$-18.4M$-34.0M$33.4M$41.9M$52.7M$104.7M$94.5M$216.3M
INCOME TAX
Tax Provision
--------$1.5M$-33.1M$13.2M$21.6M$23.1M$52.4M
NET INCOME
Net Income
$-20.2M$-18.1M$-18.4M$-34.0M$31.9M$75.0M$39.5M$83.1M$71.4M$163.9M
Net Income (Continuing Operations)
$-20.2M$-18.1M$-18.4M$-34.0M$31.9M$75.0M$39.5M$83.1M$71.4M$163.9M
Net Income (Discontinued Operations)
$-20.2M$-18.1M$-18.4M$-34.0M$31.9M$75.0M$39.5M$83.1M$71.4M$163.9M
Net Income (Common Stockholders)
$-20.2M$-18.1M$-18.4M$-34.0M$31.9M$75.0M$39.5M$83.1M$71.4M$163.9M
Normalized Income
------------------$214.1M
TOTALS
Total Expenses
$-20.4M$-19.3M$-18.7M$35.8M$70.5M$77.8M$88.4M$112.4M$278.8M$259.2M
SHARE & EPS DATA
Average Shares Outstanding
$80.9M$82.9M$85.8M$102.6M$102.9M$103.5M$103.4M$103.4M$106.3M$118.5M
Average Shares Outstanding (Diluted)
$80.9M$82.1M$87.7M$102.6M$106.0M$106.2M$107.8M$111.4M$113.8M$124.9M
Shares Outstanding
$82.9M$83.0M$102.6M$102.7M$103.4M$103.8M$102.7M$105.7M$117.9M$121.4M
Basic EPS
------$-0.33$0.31$0.72$0.38$0.80$0.67$1.38
Basic EPS (Continuing Operations)
--------$0.31$0.72$0.38$0.80$0.67$1.38
Diluted EPS
$-0.25$-0.22$-0.21$-0.33$0.30$0.71$0.37$0.75$0.63$1.31
Diluted EPS (Continuing Operations)
--------$0.30$0.71$0.37$0.75$0.63$1.31
OTHER METRICS
Non Recurring Operation Expense
$3.5M------------------
Other Gand A
$8.6M$7.9M$7.3M$-242.2K$36.9M$44.2M$49.6M$57.1M$133.7M$177.7M
Rent And Landing Fees
$8.6M$7.9M$7.3M$-242.2K$318.3K$278.8K--------
Selling Expense
------$15.9M--------$91.5M$118.7M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CPRX$20.59+1.0%814.40K
3
4
5
6

Get Catalyst Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.